Medications

Illicit opioid trade up with restrictions on hydrocodone

(HealthDay)—The U.S. Drug Enforcement Administration's 2014 ruling to reschedule hydrocodone combination products coincided with an increase in illicit trading of opioids through online illicit markets (cryptomarkets), ...

Medications

The other opioid crisis: shortages at U.S. hospitals

(HealthDay)—U.S. hospitals are running short of the injectable opioids and anesthesia drugs that most surgery patients need during and after their procedures, a new survey shows.

Medications

Hydrocodone combo products reclassified as Schedule II

(HealthDay)—A new rule taking effect Oct. 6 reclassifies hydrocodone combination products as Schedule II controlled substances, which will impact prescribing practices for these products, according to a report from the ...

Medical research

Lacking quality weed extract, US researchers turn to Canada

In a rare move, the U.S. government has approved the importation of marijuana extracts from Canada for a clinical trial, highlighting a new avenue for American researchers who have long had trouble obtaining the drug for ...

Medications

US painkiller restriction linked to increase in drug trading

A new study led by Swinburne shows trading of prescription opioids through the darknet has increased in the wake of tighter regulation by the US government for this category of legal pharmaceutical products prescribed by ...

Medications

Judge overseeing opioid lawsuits orders release of some data

A look at how the opioid crisis grew and spread may be much clearer soon after a federal judge overseeing nearly 2,000 lawsuits filed against manufacturers, distributors and retailers of prescription painkillers ordered the ...

Medications

Medical marijuana advocates want drug reclassified

(AP)—A federal appeals court in Washington is considering whether marijuana should be reclassified from its current status as a dangerous drug with no accepted medical use.

page 7 from 13